Apheresis Equipment Market by Product, Procedure, Technology, Application

List of Tables

[193 Pages Report] The Apheresis Equipment Market size was estimated at USD 2.90 billion in 2023 and expected to reach USD 3.15 billion in 2024, at a CAGR 9.06% to reach USD 5.32 billion by 2030.

Apheresis equipment refers to medical devices used in apheresis, a medical procedure that involves removing whole blood from a patient or donor, separating it into individual components, and retaining one or more of these components while the rest are returned to the patient or donor. The separation process can isolate and collect components such as plasma (the liquid part of the blood), platelets (cells that help blood to clot), red blood cells, and white blood cells. Increased incidence of conditions that require blood component therapies, such as cancer and autoimmune diseases, drives demand for apheresis procedures. Technological innovations in apheresis equipment, making procedures more efficient and safe, also fuel market growth. Enhanced awareness regarding the availability of apheresis treatments for various conditions supports market expansion. However, a lack of awareness about the benefits of apheresis treatments may hinder market growth. Stringent regulatory requirements for approval of new devices may delay product launches and increase development costs, creating challenges for market growth. Moreover, innovation in apheresis technologies, such as automation and integrated systems, offers the potential for capturing new market segments. Increasing healthcare investments in emerging economies present significant opportunities for market expansion.

KEY MARKET STATISTICS
Base Year [2023]	USD 2.90 billion
Estimated Year [2024]	USD 3.15 billion
Forecast Year [2030]	USD 5.32 billion
CAGR (%)	9.06%

Regional Insights

In the Americas, with a particular focus on the United States and Canada, there is a high demand for apheresis equipment due to the developed healthcare infrastructure, high awareness levels about blood donation, and the prevalence of diseases requiring plasma and other blood components for treatment. Recent investments have been directed toward enhancing the efficiency and safety of apheresis procedures, with several patents filed in the Americas region, aiming to minimize contamination risks and improve automated separation processes. European countries exhibit robust demand for apheresis equipment, driven by strict regulations pertaining to blood donation and handling, as well as a strong focus on healthcare research and development. The Middle East and Africa region presents a varied landscape for apheresis equipment, with certain countries rapidly developing their healthcare infrastructure, contributing to the market growth in the region. The APAC region, particularly China, Japan, and India, is witnessing substantial growth in demand for apheresis equipment. The surge in adoption of apheresis equipment in the APAC region is propelled by increasing healthcare expenditure, rising awareness about the importance of blood donation, and a growing prevalence of chronic diseases. In Japan, the market is characterized by a preference for technologically advanced equipment, while in China and India, there's a focus on cost-effectiveness and scalability to meet the large population's needs.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Apheresis Equipment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of chronic diseases
- Technological innovations in apheresis equipment
- Enhanced awareness regarding the availability of apheresis treatments

Market Restraints
- Lack of awareness and high cost of apheresis equipment

Market Opportunities
- Increasing healthcare investments in emerging economies
- Customization and flexibility in apheresis equipment

Market Challenges
- Stringent regulatory requirements for the approval of new devices

Market Segmentation Analysis
- Product: Increasing significance of disposable apheresis kits due to its critical role in maintaining hygiene and preventing infection
- Application: Increasing prevalence of renal diseases driving the need for advanced apheresis equipment

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Apheresis Equipment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Apheresis Equipment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Enhancing Sickle Cell Treatment in England, A GBP 1.5 Million Investment in Advanced Apheresis Technology

In a significant development aimed at improving healthcare services for sickle cell disease patients in England, NHS England has announced a GBP 1.5 million (USD 1.8 million) investment to acquire 25 Spectra Optia Apheresis System devices. The automated red blood cell exchange offered by the Spectra Optia device aims to minimize these transfusions and also to manage pain more effectively and reduce the risk of crises. [Published On: 2024-02-14]

Revolutionizing Cell & Gene Therapy, A Transformative Partnership between Be The Match BioTherapies and Cryoport

Be The Match BioTherapies and Cryoport have embarked on a strategic alliance that greatly enhances the capabilities of IntegriCell, an integrated bioprocessing, cryopreservation, and distribution platform catering to the global cell therapy sector. This groundbreaking collaboration aims to streamline the entire bioprocessing and cryopreservation journey-spanning from the U.S. to Europe-by merging Be The Match BioTherapies' expertise in donor management and high-quality material collection with Cryoport's advanced cryopreservation, bioprocessing, and global logistics solutions. [Published On: 2023-10-09]

Sanguine Biosciences Opens Innovative Blood Donor Center for Enhanced Biomedical Research

Sanguine Biosciences has launched a cutting-edge blood donor center in Los Angeles, California, marking a significant milestone in precision medicine research and development. This facility is dedicated to the collection of concentrated white blood cell biospecimens, also known as leukopaks, from its extensive Patient Community network. This development underscores Sanguine's ambition to be at the forefront of providing valuable translational biospecimens to the biomedical research sector, leveraging its powerful patient engagement strategies and robust procurement capabilities. [Published On: 2023-09-13]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Apheresis Equipment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Apheresis Equipment Market, highlighting leading vendors and their innovative profiles. These include Aikang Diagnostics Co., Ltd., Asahi Kasei Kuraray Medical Co. Ltd., B. Braun Melsungen AG, Bioelettronica S.r.l., Braun & Co. Limited, Cerus Corporation, Charles River Laboratories International, Inc., Cytosorbents Corporation, Delcon S.r.l., Fresenius Kabi AG, Haemonetics Corporation, Isto Biologics, JMS North America Corporation, Kaneka Corporation, LMB Technologie GmbH, Maco Pharma SAS, Mallinckrodt Pharmaceuticals Ireland Limited, MEDICA S.P.A., Medicap Clinic GmbH, Micro Technologies, Miltenyi Biotec B.V. & Co. KG, Nikkiso Co., Ltd., SB-Kawasumi Laboratories, Inc., and Terumo BCT Inc..

Market Segmentation & Coverage

This research report categorizes the Apheresis Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Apheresis Machine
- Disposable Apheresis Kits

Procedure
- Erythrocytapheresis
- LDL-Apheresis
- Leukapheresis
- Photopheresis
- Plasmapheresis
- Plateletpheresis

Technology
- Centrifugation
  - Continuous Flow Centrifugation
  - Intermittent Flow Centrifugation

Membrane Filtration

Application
- Hematology
- Neurology
- Renal Diseases

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-ED54C46E8736

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of chronic diseases
  - 5.1.1.2. Technological innovations in apheresis equipment
  - 5.1.1.3. Enhanced awareness regarding the availability of apheresis treatments
- 5.1.2. Restraints
  - 5.1.2.1. Lack of awareness and high cost of apheresis equipment
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing healthcare investments in emerging economies
  - 5.1.3.2. Customization and flexibility in apheresis equipment
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory requirements for the approval of new devices
5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing significance of disposable apheresis kits due to its critical role in maintaining hygiene and preventing infection
- 5.2.2. Application: Increasing prevalence of renal diseases driving the need for advanced apheresis equipment
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Apheresis Equipment Market, by Product

6.1. Introduction
6.2. Apheresis Machine
6.3. Disposable Apheresis Kits

7. Apheresis Equipment Market, by Procedure

7.1. Introduction
7.2. Erythrocytapheresis
7.3. LDL-Apheresis
7.4. Leukapheresis
7.5. Photopheresis
7.6. Plasmapheresis
7.7. Plateletpheresis

8. Apheresis Equipment Market, by Technology

8.1. Introduction
8.2. Centrifugation
8.3. Membrane Filtration

9. Apheresis Equipment Market, by Application

9.1. Introduction
9.2. Hematology
9.3. Neurology
9.4. Renal Diseases

10. Americas Apheresis Equipment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Apheresis Equipment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Apheresis Equipment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Enhancing Sickle Cell Treatment in England, A GBP 1.5 Million Investment in Advanced Apheresis Technology
- 13.3.2. Revolutionizing Cell & Gene Therapy, A Transformative Partnership between Be The Match BioTherapies and Cryoport
- 13.3.3. Sanguine Biosciences Opens Innovative Blood Donor Center for Enhanced Biomedical Research
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio